Trial intelligence / Profile preview

Preoperative intraarticular methylprednisolone for pain after total knee arthroplasty

2014-002744-40Phase 2Completed

Sponsor
Section for Surgical Pathophysiology, Rigshospitalet
Start
Jul 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of methylprednisolone in knee osteoarthritis (OA), sponsored by Section for Surgical Pathophysiology, Rigshospitalet. Primary endpoint: Pain during 5 meter walk test at 24 hours. Started Jul 2014; status: completed.

02

Drugs

methylprednisolone
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2014-002744-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002744-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call